Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease
Primary Purpose
Peripheral Arterial Disease
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Yoga intervention
Sponsored by
About this trial
This is an interventional supportive care trial for Peripheral Arterial Disease
Eligibility Criteria
Inclusion Criteria:
- Age > 40
- Diagnosis of lower extremity PAD (defined as a documented ankle-brachial index of < 0.9)
- Do less than 150 minutes of exercise per week
- Competent to give informed consent
Exclusion Criteria:
- Life expectancy under 1 year
- Pregnancy
- Co-morbidities which limit physical activity to a severe degree (unable to walk at least a block)
- Signs of critical limb ischemia and/or planned revascularization in the next 12-months
- Recent CVD event (< 3 months) including stroke/transient ischemic attack (TIA), myocardial infarction (MI), unstable angina (UA), percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG), or severe valve disease, congenital heart disease, complex arrhythmias (untreated), NYHA class III-IV heart failure
- Recent or current enrollment in formal exercise or yoga program
- Psychiatric disorder, which limits subjects ability to follow the study protocol
- Current substance abuse
- Non-English speaking
Sites / Locations
- University of Michigan
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Yoga intervention
Wait list control
Arm Description
Outcomes
Primary Outcome Measures
To test the acceptability of a yoga program for patients with PAD. We will evaluate drop-out rates (<15%), attendance (>80% classes attended), and completion of the home-based practices sessions (self-report >80% completed).
Secondary Outcome Measures
To test the feasibility of a yoga program for patients with PAD.
Feasibility will be determined by numbers of potential participants approached, and those who consent to participate vs. those who do not.
To test the effectiveness of a yoga program to improve maximal walking distance among participants with PAD.
To test the effectiveness of a yoga program to reduce claudication symptoms among participants with PAD.
To test the effectiveness of a yoga program to improve health-related quality of life among participants with PAD.
Full Information
NCT ID
NCT02007525
First Posted
November 22, 2013
Last Updated
December 11, 2015
Sponsor
University of Michigan
1. Study Identification
Unique Protocol Identification Number
NCT02007525
Brief Title
Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease
Official Title
Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Terminated
Why Stopped
Insufficient enrollment; non-interest by target sample
Study Start Date
February 2013 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
4. Oversight
5. Study Description
Brief Summary
The investigators propose to pilot test a six-week yoga program among adults with peripheral arterial disease (PAD). Participants (n=50) will be randomized to a six-week yoga intervention (n=25) or wait-list control (n=25). The yoga intervention will include a weekly yoga class currently used among cardiac rehab patients at the University of Michigan Health System, together with home-based practice sessions. Participants will perform treadmill testing at baseline and 6 weeks to assess walking capacity. The primary outcomes of interest include 1) acceptability of the program by participants, 2) feasibility of recruitment, 3) change in maximal walking distance, 4) change in claudication symptoms, and 5) change in health-related quality of life (HRQOL). The investigators expect this will inform us on the acceptability and feasibility of a larger proposal examining yoga in PAD patients. These data will also inform on the effect size in maximal walking, and HRQOL, which will be used to estimate the sample size needed for a larger R01 level proposal.
Study hypotheses:
Hypothesis 1: Participants will find the yoga program acceptable with low drop-out rates (<15%), excellent attendance (>80% classes attended), and good completion of the home-based practice sessions (self-report >80% completed).
Hypothesis 2: The yoga intervention will be feasible for a larger study based on numbers of potential participants approached, and those who consent to participate vs. those who do not.
Hypothesis 3: Increases in maximal walking distance and pain-free walking distance (from baseline to 6 weeks) will be greater in the participants randomized to the yoga intervention compared to the control group.
Hypothesis 4: Self-reported claudication symptoms will be reduced to a greater degree (at 6 weeks) among participants randomized to the yoga intervention compared to the control group.
Hypothesis 5: Increases in HRQOL (from baseline to 6 weeks) will be greater in the participants randomized to the yoga intervention compared to the control group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Disease
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Yoga intervention
Arm Type
Experimental
Arm Title
Wait list control
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Yoga intervention
Intervention Description
Participants will attend one weekly 60 minute hatha yoga class taught by a certified yoga instructor for 6 weeks. Each participant is to practice yoga at home 3-5 days per week. Paper logs will be provided to record date, time and duration of yoga practice each week.
Primary Outcome Measure Information:
Title
To test the acceptability of a yoga program for patients with PAD. We will evaluate drop-out rates (<15%), attendance (>80% classes attended), and completion of the home-based practices sessions (self-report >80% completed).
Time Frame
After 6 weeks
Secondary Outcome Measure Information:
Title
To test the feasibility of a yoga program for patients with PAD.
Description
Feasibility will be determined by numbers of potential participants approached, and those who consent to participate vs. those who do not.
Time Frame
At end of study
Title
To test the effectiveness of a yoga program to improve maximal walking distance among participants with PAD.
Time Frame
Baseline and 6 weeks
Title
To test the effectiveness of a yoga program to reduce claudication symptoms among participants with PAD.
Time Frame
Baseline and 6 weeks
Title
To test the effectiveness of a yoga program to improve health-related quality of life among participants with PAD.
Time Frame
Baseline and 6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
41 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 40
Diagnosis of lower extremity PAD (defined as a documented ankle-brachial index of < 0.9)
Do less than 150 minutes of exercise per week
Competent to give informed consent
Exclusion Criteria:
Life expectancy under 1 year
Pregnancy
Co-morbidities which limit physical activity to a severe degree (unable to walk at least a block)
Signs of critical limb ischemia and/or planned revascularization in the next 12-months
Recent CVD event (< 3 months) including stroke/transient ischemic attack (TIA), myocardial infarction (MI), unstable angina (UA), percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG), or severe valve disease, congenital heart disease, complex arrhythmias (untreated), NYHA class III-IV heart failure
Recent or current enrollment in formal exercise or yoga program
Psychiatric disorder, which limits subjects ability to follow the study protocol
Current substance abuse
Non-English speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth A. Jackson, MD MPH FACC
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48106
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease
We'll reach out to this number within 24 hrs